Annotation Detail for FGF9
Basic Information Top
Gene Symbol: | FGF9 ( GAF,HBFG-9,MGC119914,MGC119915,SYNS3 ) |
---|---|
Gene Full Name: | fibroblast growth factor 9 (glia-activating factor) |
Band: | 13q12.11 |
Quick Links | Entrez ID:2254; OMIM: 600921; Uniprot ID:FGF9_HUMAN; ENSEMBL ID: ENSG00000102678; HGNC ID: 3687 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C026486 | 1,2,5,6-dibenzanthracene | 1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA | increases expression | 19358281 |
C038890 | 2,3,4,7,8-pentachlorodibenzofuran | 2,3,4,7,8-pentachlorodibenzofuran results in increased expression of FGF9 mRNA | increases expression | 19358281 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FGF9 mRNA | increases expression | 19358281 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
D019386 | Alendronate | Alendronate affects the expression of FGF9 mRNA | affects expression | 16079270 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FGF9 mRNA | affects expression | 16483693 |
C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of FGF9 mRNA | increases expression | 19358281 |
C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of FGF9 mRNA | increases expression | 19358281 |
D001564 | Benzo(a)pyrene | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FGF9 mRNA | increases expression | 19358281 20464547 16002475 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FGF9 protein | increases expression | 20464547 |
D001564 | Benzo(a)pyrene | PD 98059 inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGF9 mRNA | increases expression | 20382639 |
D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of FGF9 mRNA | increases expression | 17720352 |
D002118 | Calcium | Calcium affects the expression of FGF9 mRNA | affects expression | 15913539 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of FGF9 protein | increases expression | 17662249 |
D004390 | Chlorpyrifos | Chlorpyrifos affects the expression of FGF9 mRNA | affects expression | 18502319 |
D003976 | Diazinon | Diazinon affects the expression of FGF9 mRNA | affects expression | 19130878 |
D002945 | Cisplatin | FGF9 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747 |
D004026 | Dieldrin | Dieldrin results in increased expression of FGF9 mRNA | increases expression | 19130878 |
D004958 | Estradiol | Estradiol results in increased expression of FGF9 mRNA | increases expression | 21098263 12072406 14602803 |
D004958 | Estradiol | Estradiol results in increased expression of FGF9 protein | increases expression | 12072406 |
D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of FGF9 mRNA | affects cotreatment|decreases expression | 17404688 |
D004967 | Estrogens | FGF9 protein promotes the reaction [Estrogens results in increased expression of TBX3 protein] | increases expression|increases reaction | 21098263 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of FGF9 mRNA | affects expression | 16079270 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of FGF9 mRNA | decreases expression | 16551644 |
C070081 | fulvestrant | fulvestrant results in decreased expression of FGF9 mRNA | decreases expression | 14602803 |
C051890 | irinotecan | irinotecan analog results in decreased expression of FGF9 mRNA | decreases expression | 18927307 |
C004809 | isopentenyl pyrophosphate | isopentenyl pyrophosphate results in increased expression of FGF9 mRNA | increases expression | 14704367 |
C004809 | isopentenyl pyrophosphate | isopentenyl pyrophosphate results in increased expression of FGF9 protein | increases expression | 14704367 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of FGF9 mRNA | increases expression | 12057914 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein | affects cotreatment|increases expression | 12639846 |
D009151 | Mustard Gas | IL10 protein affects the reaction [Mustard Gas affects the expression of FGF9 mRNA] | affects expression|affects reaction | 16173061 |
D010126 | Ozone | Ozone results in decreased expression of FGF9 mRNA | decreases expression | 12763052 |
D052638 | Particulate Matter | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of FGF9 mRNA | increases expression | 20464547 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of FGF9 protein | increases expression | 20464547 |
D052638 | Particulate Matter | PD 98059 inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
C093973 | PD 98059 | PD 98059 inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
C093973 | PD 98059 | PD 98059 inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | decreases reaction|increases expression | 20464547 |
C008954 | polychlorodibenzo-4-dioxin | polychlorodibenzo-4-dioxin results in increased expression of FGF9 mRNA | increases expression | 19358281 |
D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of FGF9 mRNA | increases expression | 16002475 20464547 |
D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of FGF9 mRNA | increases expression | 16002475 |
D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of FGF9 mRNA | affects cotreatment|decreases expression | 17404688 |
D020849 | Raloxifene | Raloxifene affects the expression of FGF9 mRNA | affects expression | 16079270 |
D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF9 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16150908 |
D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF9 protein results in increased phosphorylation of MAPK3 protein] | increases phosphorylation|increases reaction | 16150908 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGF9 mRNA | increases expression | 19358281 20106945 |
D013935 | Thymic Factor, Circulating | [Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein | affects cotreatment|increases expression | 12639846 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of FGF9 mRNA | increases expression | 20464547 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGF9 mRNA | increases expression | 7656983 15621532 |
C066075 | vanadium pentoxide | vanadium pentoxide results in decreased expression of FGF9 mRNA | decreases expression | 17459161 |
D015032 | Zinc | [Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein | affects cotreatment|increases expression | 12639846 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.45 | 15322242 14514962 11752688 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 3.15 | 18287403 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.53 | 17505938 | |
MESH:D000169 | Acrodermatitis | Zinc | 5.00 | 16889938 17190629 17202136 | |
MESH:D058186 | Acute Kidney Injury | Cisplatin | 3.60 | 17670903 15814532 12690470 | |
MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 8.57 | 11850527 18653653 | |
MESH:D055371 | Acute Lung Injury | Particulate Matter | 8.57 | 12396868 | |
MESH:D000230 | Adenocarcinoma | marker/mechanism | 20464547 | ||
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 9.19 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Cisplatin | 9.19 | 11798837 17638652 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 9.19 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 9.19 | 14692618 | |
MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Tobacco Smoke Pollution | 5.11 | 15814487 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 2.41 | 6695378 | |
MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 9.19 | 16628245 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.19 | 16835633 | |
MESH:D000382 | Agricultural Workers' Diseases | Chlorpyrifos | 7.83 | 17119214 16611668 11874814 | |
MESH:D000382 | Agricultural Workers' Diseases | Diazinon | 7.83 | 16487989 | |
MESH:D000419 | Albuminuria | Raloxifene | 4.21 | 17308373 17451421 | |
MESH:D000505 | Alopecia | Tretinoin | 3.29 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Ozone | 8.66 | 15513908 | |
MESH:D000544 | Alzheimer Disease | Particulate Matter | 8.66 | 15513908 | |
MESH:D000544 | Alzheimer Disease | Raloxifene | 8.66 | 15800139 | |
MESH:D000544 | Alzheimer Disease | Zinc | 8.66 | 17119284 16325427 16410023 16580781 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.60 | 11748828 | |
MESH:D000755 | Anemia, Sickle Cell | Zinc | 4.51 | 16916123 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.68 | 19183758 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 3.07 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 6.35 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 6.35 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Ozone | 6.87 | 15570426 | |
MESH:D001172 | Arthritis, Rheumatoid | Tobacco Smoke Pollution | 6.87 | 19898480 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.87 | 16292516 | |
MESH:D001249 | Asthma | Mustard Gas | 10.17 | 10378619 | |
MESH:D001249 | Asthma | Ozone | 10.17 | 16373670 17854713 | |
MESH:D001249 | Asthma | Tretinoin | 10.17 | 16456186 | |
MESH:D001249 | Asthma | Zinc | 10.17 | 17085522 | |
MESH:D001284 | Atrophy | fulvestrant | 4.46 | 11514358 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 4.02 | 16935849 | |
MESH:D001768 | Blister | Mustard Gas | 4.75 | 19167455 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 7.73 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 7.73 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.38 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.50 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 4.47 | 14601052 | |
MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.92 | 17868700 | |
MESH:D001930 | Brain Injuries | Progesterone | 16.16 | 15665606 15380490 15845082 | |
MESH:D001930 | Brain Injuries | Raloxifene | 16.16 | 16580743 | |
MESH:D001930 | Brain Injuries | Zinc | 16.16 | 17109824 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 6.48 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 6.48 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Cisplatin | 6.48 | 19526202 18382427 | |
MESH:D001943 | Breast Neoplasms | Dieldrin | 6.48 | 11859874 15770527 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 6.48 | 17261762 17289903 17018787 12948864 18497071 16675129 19861407 14630087 | |
MESH:D001943 | Breast Neoplasms | fulvestrant | 6.48 | 18984771 | |
MESH:D001943 | Breast Neoplasms | Progesterone | 6.48 | 15562024 17614352 16175315 | |
MESH:D001943 | Breast Neoplasms | Raloxifene | 6.48 | 16912660 17595753 15572757 17261762 16837676 17440819 15775269 17049068 15758505 17242785 17952589 17893378 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 6.48 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 6.48 | 16873071 16443354 16166294 | |
MESH:D016535 | Bronchial Hyperreactivity | Ozone | 3.36 | 17626835 15516495 14754758 18417511 16777450 18315731 19059883 | |
MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 4.75 | 15286001 | |
MESH:D001991 | Bronchitis | vanadium pentoxide | 5.82 | 17459161 | |
MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 4.56 | 17687719 10378619 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.18 | 16813970 | |
MESH:D002100 | Cachexia | Ozone | 4.33 | 16183385 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 4.06 | 16111702 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 3.38 | 18705752 15700767 16097048 15673190 16192424 15721981 10355542 16227642 16050911 3786805 16011737 16124888 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.48 | 16835633 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.74 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 8.08 | 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 8.08 | 17982673 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 8.08 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 8.08 | 15341023 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 8.08 | 1917145 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | marker/mechanism | 19358281 | ||
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 5.43 | 12023789 16685392 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Tobacco Smoke Pollution | 5.43 | 11212258 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 12.93 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 12.93 | 17066447 18337622 6189445 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tobacco Smoke Pollution | 12.93 | 11212258 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 12.93 | 16096774 16051514 | |
MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 12.93 | 16543248 | |
MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 3.72 | 17572228 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.14 | 18850075 16120746 18670907 | |
MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 10.82 | 12396868 | |
MESH:D002318 | Cardiovascular Diseases | Raloxifene | 10.82 | 15775269 | |
MESH:D002318 | Cardiovascular Diseases | Zinc | 10.82 | 16936243 | |
MESH:D002386 | Cataract | Tretinoin | 2.85 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 5.71 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 5.71 | 18566989 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.18 | 16129372 | |
MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 8.68 | 16628245 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.68 | 16835633 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 2.57 | 11677210 17681005 17110522 16919318 15861022 16105132 17333356 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.74 | 16461808 | |
MESH:D002971 | Cleft Lip | marker/mechanism | 17963255 | ||
MESH:D002972 | Cleft Palate | marker/mechanism | 17963255 | ||
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.16 | 8697196 15668235 15340226 16354765 12621046 | |
MESH:D002972 | Cleft Palate | Tretinoin | 5.16 | 9407595 | |
MESH:D003072 | Cognition Disorders | Raloxifene | 4.22 | 15800139 | |
MESH:D003092 | Colitis | Tretinoin | 3.31 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | irinotecan | 2.52 | 17287894 17725105 | |
MESH:D015179 | Colorectal Neoplasms | Cisplatin | 2.74 | 15273666 | |
MESH:D015179 | Colorectal Neoplasms | irinotecan | 2.74 | 15273666 16391804 17159606 18259882 17454858 16303861 18509181 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.72 | 17141729 14669216 | |
MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 5.04 | 17686920 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 5.04 | 15322242 10048152 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 5.04 | 9125849 10589399 9224671 17551590 9142499 16925845 8800419 9664655 14991402 9211117 | |
MESH:D019465 | Craniofacial Abnormalities | Zinc | 5.04 | 19302082 | |
MESH:D016638 | Critical Illness | Estrogens | 5.54 | 16670151 | |
MESH:D003865 | Depressive Disorder, Major | Raloxifene | 3.82 | 17474826 | |
MESH:D003920 | Diabetes Mellitus | Zinc | 3.86 | 16479319 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 1.56 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 7.88 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Raloxifene | 7.88 | 15920148 17451421 17308373 | |
MESH:D003929 | Diabetic Neuropathies | Progesterone | 4.09 | 17187935 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 3.30 | 10915739 3786805 16177239 19336974 9327722 11566570 17522070 15998439 4309450 7179309 16227642 10092053 15968718 15027814 7120509 3732212 19085960 6884620 6623471 2869522 7440962 21278145 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 3.30 | 20420201 | |
MESH:D004362 | Drug Toxicity | Cisplatin | 7.18 | 12649298 12231392 15033597 19839026 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 7.18 | 11462148 | |
MESH:D004417 | Dyspnea | Diazinon | 4.39 | 16487989 | |
MESH:D004487 | Edema | Mustard Gas | 9.47 | 11402378 9260866 11428631 11428647 | |
MESH:D004487 | Edema | Raloxifene | 9.47 | 15860553 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 9.47 | 12711302 11000095 | |
MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 18.70 | 17686920 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 18.70 | 15322242 18230668 16714409 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 18.70 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 13.15 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 13.15 | 17692515 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 13.15 | 15845917 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 6.52 | 11473722 18566989 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 6.52 | 16569247 | |
MESH:D004715 | Endometriosis | 2,3,4,7,8-pentachlorodibenzofuran | 13.49 | 9294722 | |
MESH:D004715 | Endometriosis | Progesterone | 13.49 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 13.49 | 9294722 10568697 | |
MESH:D019446 | Endotoxemia | Lipopolysaccharides | 3.99 | 17637181 15821434 15328337 | |
MESH:D004890 | Erythema | Mustard Gas | 4.75 | 9357497 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 9.44 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 9.44 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Cisplatin | 9.44 | 17638652 15464296 16785472 15173087 16481741 | |
MESH:D004938 | Esophageal Neoplasms | Zinc | 9.44 | 16543248 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 7.83 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 7.83 | 9664655 16938888 | |
MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 11.07 | 61145 15959796 16239168 12631006 19224547 12795759 16045604 17595544 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 11.07 | 15345470 | |
MESH:D005234 | Fatty Liver | Raloxifene | 11.07 | 17473493 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.06 | 11858732 | |
MESH:D005334 | Fever | Lipopolysaccharides | 3.66 | 9205823 11852909 | |
MESH:D005355 | Fibrosis | Carbon Tetrachloride | 12.47 | 18705752 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 12.47 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 12.47 | 17994277 | |
MESH:D005756 | Gastritis | Zinc | 4.38 | 17241300 | |
MESH:D005909 | Glioblastoma | Tretinoin | 2.74 | 17312396 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.18 | 10696789 | |
MESH:D006130 | Growth Disorders | Zinc | 3.70 | 17217573 | |
MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 6.99 | 15102660 15464296 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 6.99 | 16096774 | |
MESH:D034381 | Hearing Loss | Cisplatin | 3.96 | 19898482 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.74 | 16084493 | |
MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 4.09 | 15464296 | |
MESH:D006330 | Heart Defects, Congenital | 2,3,4,7,8-pentachlorodibenzofuran | 28.33 | 11294989 | |
MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 28.33 | 20471113 17686920 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 28.33 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | benzo(k)fluoranthene | 28.33 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | polychlorodibenzo-4-dioxin | 28.33 | 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 28.33 | 11294989 10048152 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 28.33 | 9664655 14991402 | |
MESH:D006331 | Heart Diseases | Raloxifene | 3.25 | 11110106 | |
MESH:D006333 | Heart Failure | Zinc | 3.36 | 17162251 | |
MESH:D006335 | Heart Injuries | Zinc | 5.35 | 17074742 | |
MESH:D016481 | Helicobacter Infections | Zinc | 4.16 | 17241300 | |
MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 4.03 | 16366002 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.97 | 11000095 | |
MESH:D006505 | Hepatitis | Carbon Tetrachloride | 8.33 | 19110552 19900420 | |
MESH:D006505 | Hepatitis | Diazinon | 8.33 | 16487989 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc | 4.29 | 17276780 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.50 | 16120746 15340226 12621046 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.62 | 15709030 | |
MESH:D006689 | Hodgkin Disease | Cisplatin | 3.26 | 16200630 16170182 | |
MESH:D019584 | Hot Flashes | Estradiol | 3.34 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.63 | 16959395 18606429 15340226 16354765 8697196 | |
MESH:D006930 | Hyperalgesia | Alendronate | 7.31 | 16769263 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 7.31 | 16870215 | |
MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 4.12 | 16899240 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.17 | 16778211 | |
MESH:D006973 | Hypertension | Raloxifene | 4.67 | 15787275 17577099 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.67 | 18850075 18670907 | |
MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 3.69 | 15338365 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.41 | 16945680 16569931 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 4.00 | 15869954 | |
MESH:D007247 | Infertility, Female | Dieldrin | 9.05 | 10630421 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 9.05 | 12013081 | |
MESH:D007248 | Infertility, Male | Diazinon | 9.82 | 12948887 16466525 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 9.82 | 17937319 | |
MESH:D007248 | Infertility, Male | fulvestrant | 9.82 | 11514358 | |
MESH:D007249 | Inflammation | Lipopolysaccharides | 13.54 | 9205823 17237260 17963957 12878042 17255318 | |
MESH:D007249 | Inflammation | Mustard Gas | 13.54 | 8975870 11428647 17524151 11428631 11428620 16001271 9260866 9357497 11402378 | |
MESH:D007249 | Inflammation | Progesterone | 13.54 | 15869954 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 13.54 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Tobacco Smoke Pollution | 13.54 | 18590791 | |
MESH:D007333 | Insulin Resistance | Estradiol | 2.70 | 16627594 16393666 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.37 | 17994277 | |
MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 4.26 | 17255318 | |
MESH:D007511 | Ischemia | Zinc | 4.23 | 16584753 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.72 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.72 | 17551590 15992940 | |
MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 4.73 | 15464296 | |
MESH:D007674 | Kidney Diseases | Cisplatin | 8.85 | 19839026 15190930 18289764 12649298 12231392 | |
MESH:D007674 | Kidney Diseases | Estradiol | 8.85 | 15618244 | |
MESH:D007674 | Kidney Diseases | Zinc | 8.85 | 16960431 | |
MESH:D007676 | Kidney Failure, Chronic | Zinc | 4.06 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 2.66 | 15610895 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 10.51 | 16316344 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 10.51 | 11231351 | |
MESH:D007889 | Leiomyoma | Raloxifene | 4.12 | 16973256 | |
MESH:D007938 | Leukemia | Tretinoin | 2.56 | 17143497 | |
MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 4.82 | 16972261 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 3.34 | 19285840 16482212 16932348 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 2.00 | 17596541 16294345 19850784 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 2.88 | 19225113 17712046 19029980 17294898 17301526 12679006 16766008 17649720 16935935 16823087 15748426 17107899 16331271 19075265 16140955 19642359 17339181 9834237 17368321 16788101 17217047 16891316 19035177 17361223 17506722 | |
MESH:D007970 | Leukopenia | Lipopolysaccharides | 4.29 | 15821434 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 3.02 | 9224671 | |
MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 2.58 | 16943688 11903743 11408273 21278145 16221502 17157831 16239168 17174718 17334410 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 6.10 | 18251166 17805973 16033810 18054572 15123356 18412020 15893842 15338365 17900296 17714472 17766677 18472332 17640975 17869086 12667390 12632514 16027843 12898905 18156304 15818738 18429990 17557913 15052691 12389079 12958196 17481882 17631135 15673190 13678700 12649538 17525996 15925388 12586293 17761835 16192424 15730626 11481614 12546737 17721639 15931870 14724832 18277467 12609069 18472094 15876570 15370692 18263696 18395914 15650968 12445418 18376398 17922224 15362042 14512876 16097048 16638106 16011737 17708605 18395095 16248980 12741479 18006644 18418968 18210741 18279442 17698563 12445421 14748882 15996030 14620537 10355542 16136751 18205269 16015684 14716833 17565644 12632512 18705752 18187930 18481824 17976157 17944888 18339082 17823541 15959796 18317297 20821823 14716496 18420326 15057751 12666154 16116963 18166357 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 6.10 | 14716833 14659978 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 6.10 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 6.10 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 6.10 | 18397230 16248980 | |
MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 4.04 | 15830285 17285989 15720792 16246199 16964402 | |
MESH:D008107 | Liver Diseases | Chlorpyrifos | 4.04 | 15991261 | |
MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.77 | 15123358 | |
MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 3.34 | 16899240 14706259 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 9.35 | 20195826 21137059 | |
MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 9.35 | 19294768 | |
MESH:D008113 | Liver Neoplasms | Dieldrin | 9.35 | 8742319 9539021 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 9.35 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 4.91 | 12014681 15583823 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 4.91 | 12151625 | |
MESH:D008171 | Lung Diseases | Mustard Gas | 6.70 | 18702808 18161513 | |
MESH:D008171 | Lung Diseases | Ozone | 6.70 | 19066396 8266340 | |
MESH:D055370 | Lung Injury | Lipopolysaccharides | 7.92 | 21114838 | |
MESH:D055370 | Lung Injury | Ozone | 7.92 | 20417186 | |
MESH:D008175 | Lung Neoplasms | marker/mechanism | 20464547 | ||
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 11.93 | 20464547 20135361 18816296 18520028 20064080 6695378 20869020 17053015 18569708 | |
MESH:D008175 | Lung Neoplasms | Cisplatin | 11.93 | 11798837 6189445 17225452 | |
MESH:D008175 | Lung Neoplasms | Mustard Gas | 11.93 | 8781369 3148597 | |
MESH:D008175 | Lung Neoplasms | Ozone | 11.93 | 8597069 7614698 | |
MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 11.93 | 10814675 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 11.93 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Tobacco Smoke Pollution | 11.93 | 16288123 12111688 11091918 3440675 | |
MESH:D008175 | Lung Neoplasms | vanadium pentoxide | 11.93 | 12376484 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 8.53 | 11807958 16891317 11408345 17203775 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 8.53 | 17203775 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 8.53 | 12773700 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 4.07 | 19453300 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.62 | 17453147 | |
MESH:D008545 | Melanoma | Cisplatin | 3.24 | 12393984 16432458 18176117 15577323 11135225 16248763 12374674 17023156 12883367 16809738 18332650 18505091 17761969 | |
MESH:D008545 | Melanoma | Tretinoin | 3.24 | 16752155 | |
MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 4.37 | 15990972 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 4.03 | 16940565 | |
MESH:D008654 | Mesothelioma | Cisplatin | 3.08 | 17638057 | |
MESH:D008679 | Metaplasia | Ozone | 4.69 | 10496685 | |
MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 5.14 | 15863610 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 7.76 | 16381670 | |
MESH:D009062 | Mouth Neoplasms | Tobacco Smoke Pollution | 7.76 | 15006635 | |
MESH:D052016 | Mucositis | irinotecan | 4.60 | 17159606 | |
MESH:D009101 | Multiple Myeloma | Raloxifene | 3.15 | 16497877 | |
OMIM:612961 | MULTIPLE SYNOSTOSES SYNDROME 3 | marker/mechanism | |||
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 2.84 | 17596541 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.70 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 2.97 | 16810080 | |
MESH:D009205 | Myocarditis | Particulate Matter | 5.55 | 12563109 | |
MESH:D009232 | Myxoma | Raloxifene | 5.14 | 16343187 | |
MESH:D009362 | Neoplasm Metastasis | irinotecan | 3.00 | 18259882 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 10.19 | 11141357 | |
MESH:D009369 | Neoplasms | Cisplatin | 10.19 | 16773208 | |
MESH:D009369 | Neoplasms | Dieldrin | 10.19 | 8820588 | |
MESH:D009369 | Neoplasms | Tretinoin | 10.19 | 16946489 16594593 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 3.33 | 17289903 | |
MESH:D009395 | Nephritis, Interstitial | Cisplatin | 4.08 | 15464296 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 14.10 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 14.10 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 14.10 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 2.79 | 9142499 | |
MESH:D009447 | Neuroblastoma | Cisplatin | 6.50 | 8761367 | |
MESH:D009447 | Neuroblastoma | irinotecan | 6.50 | 8761367 | |
MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 10.11 | 8761367 | |
MESH:D017599 | Neuroectodermal Tumors | irinotecan | 10.11 | 8761367 | |
MESH:D020258 | Neurotoxicity Syndromes | Chlorpyrifos | 3.89 | 15081274 | |
MESH:D009503 | Neutropenia | Mustard Gas | 3.60 | 7688884 16761898 | |
MESH:D010024 | Osteoporosis | Alendronate | 10.69 | 17882678 | |
MESH:D010024 | Osteoporosis | Calcium | 10.69 | 17882678 | |
MESH:D010024 | Osteoporosis | Raloxifene | 10.69 | 19059307 17882678 15775268 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 3.85 | 17823083 15579764 17893378 15758505 | |
MESH:D010051 | Ovarian Neoplasms | Cisplatin | 10.14 | 19769630 6897625 15464296 17225452 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 10.14 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Progesterone | 10.14 | 16525653 17393432 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 10.14 | 16936753 | |
MESH:D010146 | Pain | Tretinoin | 2.59 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 4.93 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 4.93 | 15976015 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 3.31 | 11578682 | |
MESH:D010300 | Parkinson Disease | Dieldrin | 3.37 | 16112328 17291500 16809432 11181820 11445065 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.83 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 3.92 | 15464296 | |
MESH:D010538 | Peritonitis | Ozone | 3.74 | 16369182 | |
MESH:D010997 | Pleural Neoplasms | Cisplatin | 4.93 | 17638057 | |
MESH:D011014 | Pneumonia | Lipopolysaccharides | 9.75 | 11605937 12224865 | |
MESH:D011014 | Pneumonia | Ozone | 9.75 | 18929643 18381685 18007984 | |
MESH:D011041 | Poisoning | Diazinon | 7.78 | 17603234 | |
MESH:D011041 | Poisoning | Mustard Gas | 7.78 | 15727166 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.17 | 18163543 | |
MESH:D011225 | Pre-Eclampsia | Zinc | 3.86 | 17114810 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 2.79 | 11896295 11399792 11118676 11222880 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 3.52 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.19 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.19 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Raloxifene | 2.19 | 16536755 16220300 15731164 | |
MESH:D011471 | Prostatic Neoplasms | Zinc | 2.19 | 16517595 16700911 12429649 16606632 | |
MESH:D011507 | Proteinuria | Tretinoin | 3.23 | 16636307 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 8.17 | 15861022 16919318 | |
MESH:D011537 | Pruritus | Mustard Gas | 8.17 | 18058305 | |
MESH:D011625 | Pterygium | Tretinoin | 4.38 | 16723453 | |
MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 5.78 | 10334151 17894541 17720292 17266442 17620002 | |
MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 5.78 | 12475806 | |
MESH:D011693 | Purpura | Raloxifene | 5.14 | 15770314 | |
MESH:D051437 | Renal Insufficiency | Cisplatin | 4.01 | 15464296 | |
MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 3.46 | 10835634 | |
MESH:D012135 | Respiratory Sounds | Chlorpyrifos | 8.83 | 16611668 11874814 17119214 | |
MESH:D012135 | Respiratory Sounds | Tobacco Smoke Pollution | 8.83 | 18410779 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.45 | 18990726 | |
MESH:D012140 | Respiratory Tract Diseases | Chlorpyrifos | 4.48 | 16611668 17119214 | |
MESH:D012162 | Retinal Degeneration | Zinc | 3.82 | 16584753 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 3.73 | 16283617 16116481 | |
MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.70 | 18045962 | |
MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 4.04 | 14601052 | |
MESH:D012729 | Sex Chromosome Aberrations | Chlorpyrifos | 5.67 | 6418539 | |
MESH:D012871 | Skin Diseases | Mustard Gas | 2.60 | 15451306 16961503 12880345 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 11.92 | 19755658 10029692 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 11.92 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tobacco Smoke Pollution | 11.92 | 18590791 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 11.92 | 16467112 | |
MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.93 | 15464296 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 3.53 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Progesterone | 3.87 | 15862959 16503802 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 4.36 | 2093021 20155912 | |
MESH:D013274 | Stomach Neoplasms | Cisplatin | 4.36 | 15958060 17522103 18396642 | |
MESH:D013274 | Stomach Neoplasms | irinotecan | 4.36 | 15723263 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 4.36 | 17261132 | |
MESH:D020521 | Stroke | Raloxifene | 3.50 | 16837676 | |
MESH:D013736 | Testicular Neoplasms | Cisplatin | 4.26 | 15464296 17225452 | |
MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 3.81 | 15821434 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 3.25 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.81 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.49 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 2.72 | 16026305 17045167 | |
MESH:D013978 | Tibial Fractures | Estradiol | 12.33 | 19048282 | |
MESH:D013978 | Tibial Fractures | Raloxifene | 12.33 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 8.81 | 16051514 | |
MESH:D014062 | Tongue Neoplasms | Zinc | 8.81 | 16543248 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.97 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 14.02 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 14.02 | 15537745 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 14.02 | 12973940 15464296 17225452 | |
MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 14.02 | 17572228 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tobacco Smoke Pollution | 14.02 | 12846360 | |
MESH:D014570 | Urologic Diseases | Diazinon | 4.86 | 16487989 | |
MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 8.40 | 16803524 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 8.40 | 16129372 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.92 | 14692618 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.20 | 16752155 | |
MESH:D014625 | Vaginal Neoplasms | Cisplatin | 4.21 | 15577323 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.18 | 12125929 | |
MESH:D054556 | Venous Thromboembolism | Raloxifene | 4.79 | 16837676 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 3.18 | 14671159 15869587 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.67 | 16761959 | |
MESH:D014839 | Vomiting | Cisplatin | 4.30 | 11897121 | |
MESH:D014846 | Vulvar Neoplasms | Raloxifene | 5.14 | 16343187 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.83 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.63 | 16287080 | |
MESH:D014947 | Wounds and Injuries | Estrogens | 4.41 | 11172683 |
Pathway ID | Pathway Name |
---|---|
KEGG:04010 | MAPK signaling pathway |
KEGG:05218 | Melanoma |
KEGG:05200 | Pathways in cancer |
KEGG:04810 | Regulation of actin cytoskeleton |
REACT:9470 | Signaling by FGFR |
REACT:498 | Signaling by Insulin receptor |